The Hikma v. Amarin ruling brings clarity, but not new opportunities; White House adds pandemic response staff as Ebola cases ...

Cocrystal Pharma named James Sapirstein as its CEO. Mary Lantin replaced founder Jeff Brandes as president and CEO of Azara ...

June lifts biotech funding rounds; BridgeBio nets a $1 billion raise; Why Anthropic is bringing AI to drug development.

House China panel questions Bristol Myers, Pfizer on trial sites; Eli Lilly and Regeneron selected for the FDA’s new PreCheck ...

MM+M editor-at-large Steve Madden shares encounters, conversations and updates from the International Festival of Creativity.

BioCryst announced it would close its Discovery Center of Excellence facility in Birmingham, Alabama, by the end of this year ...

Launch prices for prescription drugs fell last year; Biogen culls Apellis pipeline following deal; Sanofi in EU crosshairs ...

The 7-2 decision blocks a Missouri failure-to-warn claim and leans heavily on medical-device precedent, giving healthcare ...

The prostate cancer screening campaign launched during Super Bowl LX led the 2026 Pharma Lions, while work from Viatris, ...

Roche launches a gene sequencing machine to challenge Illumina; The Supreme Court rejected a case involving New York’s past ...

The opioid crisis helped reshape the pain conversation. What comes next depends on how effectively marketers translate that ...

The U.S. added 24 awards on day four of the Cannes Lions International Festival of Creativity — four golds, eight silvers and ...